Total 252 'Breakthrough Infections' After Domestic Vaccination: Janssen 143, Pfizer 59, AZ 50 (Update)

Vaccine administration, which had recently stalled, officially resumed on the 12th. The target groups include military enlistees mostly in their 20s and 30s, as well as caregivers for infants and young children. Pre-booking for vaccinations for people in their 50s has also begun. The photo shows the vaccination center in Seodaemun-gu, Seoul on that day. Photo by Hyunmin Kim kimhyun81@

[Asia Economy Reporter Seo So-jeong] In South Korea, a total of 252 cases of 'breakthrough infections' have been reported, where individuals tested positive for COVID-19 despite being fully vaccinated for more than two weeks.

On the 13th, the Central Disease Control Headquarters announced that this figure came from an analysis of breakthrough infection cases following vaccination to monitor the effectiveness of COVID-19 vaccines.

Among 4,167,322 fully vaccinated individuals in the country, there were a total of 252 suspected breakthrough infection cases (4.46 cases per 100,000 people).

By vaccine type, there were 143 cases for Janssen, 59 for Pfizer, and 50 for AstraZeneca.

Follow-up observations of each case showed that 2 patients (0.8% of breakthrough infection cases) progressed to severe or critical condition, and there were no deaths.

Additionally, analysis to determine infection with variant viruses is ongoing, and among 37 analyzed cases, 12 patients (32.4%) were confirmed to be infected with major variant viruses.

By variant type, the Alpha variant was the most common with 9 cases, followed by 1 case of the Beta variant and 2 cases of the Delta variant.

This content was produced with the assistance of AI translation services.